Incyte Corporation
Imidazopyridazine and imidazopyridine compounds and uses thereof

Last updated:

Abstract:

Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting ALK2 activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with ALK2 activity such as cancer. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

19 Dec 2019

Issue date:

30 Aug 2022